Single Effort in Air Temperature of Minus 10°C

June 17, 2026 updated by: Aneta Teleglow, University School of Physical Education, Krakow, Poland

Single Effort in Air Temperature of Minus 10°C Changes the Erythrocyte Aggregation Indicators in Young Healthy Men

Exercise in the cold is an attractive option for many athletes. Erythrocyte aggregation, as one of the main rheological parameters, constitutes an important indicator of microcirculation and oxygen transport capacity in the human body; therefore, its changes in response to exercise and cold are of clinical and physiological relevance. The purpose of the study was to determine the effects of a single physical effort at low temperature (-10°C) in a thermal climate chamber on the red blood cell system, erythrocyte aggregation, lactate, cortisol, and testosterone in healthy males.

Methods: The study was experimental in nature and assumed a comparison of the body response to exercise performed at reduced (-10°C) and neutral (18°C) temperatures. It involved 30 healthy males, students of physiotherapy at the University of Physical Culture in Krakow, Poland. The enrolled individuals were divided into 2 groups: group 1 (n = 15) ran in a thermal climate chamber at an air temperature of -10°C, group 2 (n = 15) ran in the fresh air at a neutral air temperature of 18°C.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

2.1 Study group characteristics The study involved 30 healthy males, students of the University of Physical Culture in Krakow, Poland, faculty of physiotherapy. Their mean body height was 178.9 ± 6.5 cm, mean body mass equaled 76.8 ± 11.3 kg. After the subjects were assigned to each group, the average body height in the experimental group (177.9 ± 5.9 cm) and in the control/neutral group (179.9 ± 7.2 cm) was calculated. The average body mass in the experimental group (73.1 ± 6.6 kg) was lower than that in the control group (81.2 ± 14.1 kg).

Simple randomization with a 1:1 allocation ratio served to randomly assign the participants to the experimental or control group. This was done before the first blood sampling, with the randomization sequence generated prior to the study. No stratification factors were used. The participants in the experimental group performed physical exertion under the conditions of low temperature (-10°C). The workout was undertaken in a thermal climate chamber in the Laboratory for Climate Technology Research and Heavy Duty Machines, Cracow University of Technology in Krakow. The thermal climate chamber meets the requirements of the PN-EN ISO/IEC 17025:2005 standard and possesses an accreditation certificate No. AB 1678, issued by the Polish Centre for Accreditation. The Laboratory for Climate Technology Research and Heavy Duty Machines is a research center accredited in the field of defense and security by the Minister of National Defense (accreditation No.: 55/MON/2018). The control group, in turn, performed the same physical effort but in the open air, in thermoneutral conditions (the air temperature was 18.1°C on the day of the study).

The experiment comprised 3 stages: (1) Before the exercise, blood samples were taken from the participants. This was performed in the morning hours on 11 May 2024 at the Blood Physiology Laboratory of the Central Research and Development Laboratory, University of Physical Culture in Krakow. (2) Both groups undertook an exertion test. (3) Blood samples were collected from all participants again after the exercise.

The study followed the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of the Regional Medical Chamber in Krakow, Poland 2.2 Research method A two-factor experimental design with repeated measures was employed in the study. Ambient temperature (low vs. thermoneutral) constituted the between-subject factor; time of measurement (pre- and post-exercise) was the within-subject factor. The study followed the design of an exploratory investigation. In the group allocation of the participants, the principle of double randomization was employed. In experimental research, where a phenomenon is induced by the researcher on purpose, its course is observed in a planned and controlled way. Therefore, the influence of particular factors on the studied parameters can be assessed. Conclusions are drawn on the basis of the discovered relationships; the accuracy of the conclusions is evaluated with a specific probability. In the present study, a significance level of α = 0.05 was assumed, corresponding to a 95% confidence level.

2.3 Parallel group technique The participants were randomly allocated to the experimental group and the control group; the double randomization principle was followed. The first measurement preceded introducing the experimental factor.

The two groups were observed but only the experimental group received the additional stimulus, namely low temperature, i.e. the experimental factor. A second measurement was then performed, allowing to evaluate the changes imposed by the intervention. Owing to the application of a control group, it was possible to state if the reported changes in erythrocyte deformability resulted from the experimental factor - and not from other variables, which were uncontrolled. Although confounding variables are not regarded as essential in the main analysis, they can impact on the research results, leading to effect misinterpretation. Here, exposure to low ambient temperature constituted the experimental factor. The testing environments were different in the two groups (controlled thermal climate chamber in the experimental group and natural outdoor conditions in the control group), which was taken into consideration when interpreting the results.

2.4 Shuttle run test In the current study, cardiorespiratory capacity was determined with the use of an endurance shuttle run test. This is a standardized, incremental protocol commonly applied to provoke progressively increasing cardiorespiratory load. Direct physiological intensity indicators were not recorded but the same protocol was used in both groups in order to obtain comparable external workload progression.

The test started with a steady pace, which equaled 8 km/h. Subsequently, the running speed increased by 0.5 km/h per minute. The subjects ran a 20-m distance back and forth and then touched the finish line with one foot. The running pace was indicated by a beep. The participant finalized the test if they failed to reach the line at a distance of at least 3 m before the beep sound for two successive running sections. The number of completed sections was considered the test result.

2.5 Methods of blood analysis A qualified nurse collected fasting blood samples in 10-ml Vacuette tubes in the morning hours. The staff at the Blood Physiology Laboratory of the Central Research and Development Laboratory, University of Physical Culture in Krakow supervised the procedure, following the applicable standards. Serum indicators were determined in the laboratory of Diagnostyka S.A. in Krakow.

2.6 Morphological assessments The morphological analyses of blood included red blood cell count (RBC) [106/mm3] and hemoglobin (HGB) [g/dl] and were performed with the use of an ABX Micros 60 analyzer (Horiba ABX SAS, Montpellier, France).

2.7 Red blood cell aggregation index A Laser-Assisted Optical Rotational Red Cell Analyzer (Lorrca) (MaxSis Lorrca®, RR Mechatronics, Zwaag, The Netherlands) was applied. The aggregation parameters of aggregation index (AI), amplitude of aggregation (AMP), and half-time kinetics of total aggregation (T½) were evaluated with the Lorrca MaxSis Osmoscan (MaxSis Lorrca®, RR Mechatronics, Zwaag, The Netherlands).

2.8 Biochemical parameters Testosterone concentration [nmol/l] was evaluated with an Alinity I, Abbott immunochemical analyzer. The level of cortisol (μg/dl) was established with chemiluminescence (Abbott, Abbott Park, IL, USA). To determine lactate concentration, the enzymatic method (ARCHITECT c System, Abbott, USA) was used.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lesser Poland Voivodeship
      • Krakow, Lesser Poland Voivodeship, Poland, 31-571
        • University of Physical Culture

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

- Healthy men

Exclusion Criteria:

  • women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single effort in air temperature of -10°C
The body response to exercise performed at reduced (-10°C) temperature
the exercise, blood samples
Experimental: Single effort in neutral (18°C) condition
The body response to exercise performed at neutral (18°C) temperature
the exercise, blood samples

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood sampling: AI
Time Frame: twice: before starting the exercise and immediately after finishing it
aggregation index
twice: before starting the exercise and immediately after finishing it
blood sampling:AMP
Time Frame: twice: before starting the exercise and immediately after finishing it
amplitude of aggregation
twice: before starting the exercise and immediately after finishing it
blood sampling: T1/2
Time Frame: twice: before starting the exercise and immediately after finishing it
half-time kinetics of total aggregation
twice: before starting the exercise and immediately after finishing it
blood sampling: RBC
Time Frame: twice: before starting the exercise and immediately after finishing it
red blood cells
twice: before starting the exercise and immediately after finishing it
blood sampling: Hb
Time Frame: twice: before starting the exercise and immediately after finishing it
hemoglobin
twice: before starting the exercise and immediately after finishing it

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Aneta Teległow, Professor, University of Physcial Eduction, Kraków, Poland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2024

Primary Completion (Actual)

May 11, 2024

Study Completion (Actual)

May 11, 2024

Study Registration Dates

First Submitted

June 2, 2026

First Submitted That Met QC Criteria

June 17, 2026

First Posted (Actual)

June 23, 2026

Study Record Updates

Last Update Posted (Actual)

June 23, 2026

Last Update Submitted That Met QC Criteria

June 17, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

laboratory measurement results, age, gender

IPD Sharing Time Frame

1 day

IPD Sharing Access Criteria

ACCESS TO DATA BY CONTACTING my email:aneta.teleglow@awf.krakow.pl

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on cold

3
Subscribe